SLC5A2 and heart failure: A recently published cohort study involving 514 consecutive elderly outpatients with heart failure, T2D, and OSA, who were not receiving CPAP therapy, reported significant improvements in polygraphic parameters in the group treated with SGLT2 inhibitors [111].